ACLY and neoplasm: Several effective ACLY inhibitors have been described, such as BMS 303141 (49), SB 204990 (50), Medica 16 (51), hydroxycitrate (52), and, recently, NDI-091143 (53); some of them being able to reduce tumor growth in vivo (35).